Elucidating Mechanisms of Loss of Heterozygosity in Diploid Cells

阐明二倍体细胞杂合性丧失的机制

基本信息

项目摘要

Project Summary Abstract Loss of heterozygosity (LOH) is the loss of the functional copy of a tumor suppressor gene in heterozygous individuals, leaving only the mutant copy, thereby contributing to cancer initiation and progression. Understanding how LOH arises in healthy cells is a vital component of cancer research, as it could lead to opportunities to prevent cancer in patients with increased early screening for individuals with mutations putting them at high risk for LOH, or with identification and targeting of cells that have undergone dangerous LOH. LOH can develop through deletions of whole chromosome arms or smaller regions of the genome, nondisjunction incidents, or homologous recombination events between homologous chromosomes (i.e., interhomolog homologous recombination, IH-HR). Despite decades of research, a critical need remains to identify the causes of LOH in normal or precancerous cells. Detecting these mechanisms in already established tumors is often difficult due to high levels of aneuploidy, ongoing chromosome instability, and DNA damage. We have recently developed a high throughput flow cytometry-based system which is sensitive for detecting LOH in normal diploid cells. Our objective is to exploit this system to identify and quantify mechanisms of LOH that arise from DNA double-strand breaks (DSBs), and the factors that modulate these events. We hypothesize that mechanisms of LOH which occur as a result of DSBs include copy number neutral LOH, as from IH-HR or non-disjunction associated with chromosome duplication and furthermore, that these events are modulated by the location of the DSB and DNA repair proteins, including proteins that act on recombination intermediates. We will address this hypothesis through the following specific aims: In Aim 1, we will investigate how proteins that act on recombination intermediates impact LOH arising from IH-HR, utilizing our flow-cytometry based system. We will assay the frequency of LOH that arises from IH-HR in the presence or absence of proteins that both prevent and contribute to crossover events, which can lead to long-range LOH. In Aim 2, we will take an unbiased approach to explore additional mechanisms of LOH arising from a DSB. We will determine how LOH mechanism is affected by the location of a DSB along a chromosome and by loss of different DSB repair pathways. This work will allow us to identify the factors that can contribute to or even prevent LOH, and give a better understanding of how these initiating events in cancer occur.
项目摘要

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Samantha Brooke Regan其他文献

Samantha Brooke Regan的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Samantha Brooke Regan', 18)}}的其他基金

Elucidating Mechanisms of Loss of Heterozygosity in Diploid Cells
阐明二倍体细胞杂合性丧失的机制
  • 批准号:
    10387419
  • 财政年份:
    2022
  • 资助金额:
    $ 4.77万
  • 项目类别:

相似海外基金

Elucidating the effects of extra chromosome elimination in mosaic aneuploidy syndromes: Pallister-Killian syndrome as a model
阐明额外染色体消除对嵌合非整倍体综合征的影响:以 Pallister-Killian 综合征为模型
  • 批准号:
    10887038
  • 财政年份:
    2023
  • 资助金额:
    $ 4.77万
  • 项目类别:
Characterization of aneuploidy, cell fate and mosaicism in early development
早期发育中非整倍性、细胞命运和嵌合体的表征
  • 批准号:
    10877239
  • 财政年份:
    2023
  • 资助金额:
    $ 4.77万
  • 项目类别:
The impact of aneuploidy on early human development
非整倍体对人类早期发育的影响
  • 批准号:
    MR/X007979/1
  • 财政年份:
    2023
  • 资助金额:
    $ 4.77万
  • 项目类别:
    Research Grant
Cell competition, aneuploidy, and aging
细胞竞争、非整倍性和衰老
  • 批准号:
    10648670
  • 财政年份:
    2023
  • 资助金额:
    $ 4.77万
  • 项目类别:
Understanding how aneuploidy disrupts quiescence in the model eukaryote Saccharomyces cerevisiae
了解非整倍体如何破坏模型真核生物酿酒酵母的静止状态
  • 批准号:
    10735074
  • 财政年份:
    2023
  • 资助金额:
    $ 4.77万
  • 项目类别:
Preventing Age-Associated Oocyte Aneuploidy: Mechanisms Behind the Drosophila melanogaster Centromere Effect
预防与年龄相关的卵母细胞非整倍性:果蝇着丝粒效应背后的机制
  • 批准号:
    10538074
  • 财政年份:
    2022
  • 资助金额:
    $ 4.77万
  • 项目类别:
Functional evaluation of kinesin gene variants associated with female subfertility and egg aneuploidy.
与女性生育力低下和卵子非整倍性相关的驱动蛋白基因变异的功能评估。
  • 批准号:
    10537275
  • 财政年份:
    2022
  • 资助金额:
    $ 4.77万
  • 项目类别:
Using CRISPR screening to uncover aneuploidy-specific genetic dependencies
使用 CRISPR 筛选揭示非整倍体特异性遗传依赖性
  • 批准号:
    10661533
  • 财政年份:
    2022
  • 资助金额:
    $ 4.77万
  • 项目类别:
FASEB SRC: The Consequences of Aneuploidy: Honoring the Contributions of Angelika Amon
FASEB SRC:非整倍体的后果:纪念 Angelika Amon 的贡献
  • 批准号:
    10467260
  • 财政年份:
    2022
  • 资助金额:
    $ 4.77万
  • 项目类别:
Comparative Analysis of Aneuploidy and Cellular Fragmentation Dynamics in Mammalian Embryos
哺乳动物胚胎非整倍性和细胞破碎动力学的比较分析
  • 批准号:
    10366610
  • 财政年份:
    2022
  • 资助金额:
    $ 4.77万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了